Fierce Healthcare April 24, 2024
Paige Minemyer

UPDATED at 1 p.m. ET on April 24

Humana pulled back its growth projections for 2025 amid concerns about Medicare Advantage rates and demographic changes.

The company’s stock dropped out of the gate and was down by 4.5% as of 1:15 p.m. ET. Humana had originally estimated between $6 and $10 in earnings per share for 2025. Humana did confirm its conservative guidance for the year, and expects about $16 in earnings per share for 2024.

Earlier this month, the Centers for Medicare & Medicaid Services finalized a 0.16% decrease in the benchmark rate in Medicare Advantage despite significant pushback from the insurance industry. Chief Operating Officer Jim Rechtin warned on Humana’s earnings call Thursday that the changes would likely...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage, Payer
Plate tectonics and the new CMS prior authorization rule | Viewpoint
Payers' Q1 revenues, profits
Key Moments From the Change Healthcare Cyberattack Senate Hearing
How AI can accelerate prior and concurrent authorization processes
‘Extremely disappointed’: Biden administration gives payers more time to comply with No Surprises Act shakeup

Share This Article